J&J | Gewinn Vor Steuern



Pre Tax Profit Veränderung Datum
AbbVie USD 4.81B 1.54B 2024-12
Abbott USD 2.03B 90M 2024-12
Amgen USD 3.38B 111M 2024-12
AstraZeneca USD 1.67B 162M 2024-12
Baxter International USD -289000000 594M 2024-12
Bayer EUR -481000000 805M 2024-12
Becton, Dickinson and Co. USD 306M 1.01B 2024-12
Biogen USD 572.2M 118.5M 2024-12
Boston Scientific USD 1.16B 82M 2024-12
Bristol-Myers Squibb USD 4.26B 226M 2024-12
CONMED USD 43.64M 3.69M 2024-12
Cooper Companies USD 168.6M 61.6M 2024-10
Dexcom USD 231.9M 5.1M 2024-12
Edwards Lifesciences USD 395.2M 42.7M 2024-12
Eli Lilly USD 5.54B 3.83B 2024-12
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 563M 2.08B 2024-12
Globus Medical USD 120.72M 23.97M 2024-12
Hologic USD 295.8M 16.6M 2024-09
Insulet USD 111.3M 26.4M 2024-12
Integra LifeSciences USD -18237000 98.27M 2024-12
Intuitive Surgical USD 2.67B 2B 2024-12
J&J USD 5.42B 1.86B 2024-12
Medtronic USD 1.54B 455M 2025-01
Merck USD 5.22B 114M 2024-12
Merit Medical Systems USD 149.99M 83.98M 2024-12
Novartis USD 4.66B 269M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
Regeneron Pharmaceuticals USD 958.1M 534.9M 2024-12
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 2.18B 1.33B 2024-12
Stryker USD 1.64B 376M 2024-12
Tandem Diabetes Care USD -91870000 69.26M 2024-12
Teva Pharmaceutical Industries USD 899M 1.22B 2024-12
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12
Zimmer Biomet Holdings USD 289M 104.4M 2024-12
Zoetis USD 773M 144M 2024-12



J&J Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.